These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2522146)

  • 1. Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children.
    Rumi MG; Romeo R; Bortolini M; Gringeri A; Zanetti AR; Mannucci PM; Colombo M
    J Med Virol; 1989 Jan; 27(1):48-51. PubMed ID: 2522146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs.
    Mannucci PM; Gringeri A; Morfini M; De Biasi R; Tirindelli MC; Tamponi G; Baudo F; Carnelli V; Ciavarella N; Colombo M
    Am J Hematol; 1988 Dec; 29(4):211-4. PubMed ID: 3189317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal response to hepatitis B vaccine in drug users.
    Rumi M; Colombo M; Romeo R; Boschini A; Zanetti A; Gringeri A; Mannucci PM
    Arch Intern Med; 1991 Mar; 151(3):574-8. PubMed ID: 1848057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine.
    Polychronopoulou-Androulakaki S; Panagiotou JP; Kostaridou S; Kyratzopoulou A; Haidas S
    Pediatr Hematol Oncol; 1996; 13(5):425-31. PubMed ID: 10897814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a five-microgram dose of hepatitis B vaccine.
    Papaevangelou G; Roumeliotou-Karayannis A; Vissoulis C; Richardson SC; Krugman S
    J Med Virol; 1985 Jan; 15(1):65-9. PubMed ID: 3155792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hepatitis B vaccination in primary school children from a village endemic for Schistosoma mansoni.
    Bassily S; Strickland GT; Abdel-Wahab MF; Esmat GE; Narooz S; el-Masry NA; Constantine NT; Struewing JP
    J Infect Dis; 1992 Aug; 166(2):265-8. PubMed ID: 1386097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses.
    Lai CL; Wong BC; Yeoh EK; Lim WL; Chang WK; Lin HJ
    Hepatology; 1993 Oct; 18(4):763-7. PubMed ID: 8406348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children.
    Hayashi J; Kashiwagi S; Kajiyama W; Ikematsu H; Noguchi A; Nomura H; Ikeda K
    J Infect; 1988 Jul; 17(1):49-55. PubMed ID: 2974467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of hepatitis B vaccination in susceptible hospital personnel.
    Chan CY; Lee SD; Tsai YT; Lo KJ
    J Gastroenterol Hepatol; 1992; 7(3):266-9. PubMed ID: 1535229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of immunization against hepatitis B virus infection in children with cancer.
    Meral A; Sevinir B; Günay U
    Med Pediatr Oncol; 2000 Jul; 35(1):47-51. PubMed ID: 10881007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a recombinant hepatitis B vaccine in patients infected with Schistosoma mansoni.
    Bassily S; Hyams KC; el-Ghorab N; el-Masry NA
    Am J Trop Med Hyg; 1990 May; 42(5):449-52. PubMed ID: 2140243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines.
    Hammond GW; Parker J; Mimms L; Tate R; Sekla L; Minuk G
    Vaccine; 1991 Feb; 9(2):97-100. PubMed ID: 1829306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.